Aptilon Announces Appointment of a New Director and Grant of Options
Montréal, Québec, December 4, 2009 – Aptilon Corporation (“Aptilon” or the “Corporation”) (TSX-V: APZ), an innovative leader of on-line marketing services to physicians, today announced the appointment of Mr. Robert Steinfeld to the Corporation’s board of directors.
Robert H. Steinfeld, LL.M., J.D., served as Senior Vice President, General Counsel and Corporate Secretary of IMS Health Inc. from 2000 to 2009. He joined Cognizant Corporation in February, 1997 as Director of Taxes. He played a key role in the structuring of the IMS-Gartner Group spin-off and also in the Synavant spin-off. From September 1993 to February, 1997, Mr. Steinfeld served as Vice President, Taxation at Ultramar Corporation. Mr. Steinfeld earned a BA from Columbia University in 1975, a JD from the Columbia University School of Law in 1978, and an LLM in Taxation from the New York University School of Law in 1981.
The Corporation’s board of directors is now comprised of Roger Korman, Chairman & CEO, Denis Martineau, President, Mark Benthin, COO, Justin Beckett, Robert Boisjoli, Tommy Boman, André Brosseau and Robert Steinfeld.
Aptilon has also granted a total of 7,580,000 stock options, of which 6,200,000 were issued to directors and officers. Each option is valid for five years, is exercisable at a price of $0.105. One-twelfth of the options granted vest on each quarterly anniversary of date of the grant over a total period of three years.
Aptilon also announces that further to its acquisition of the assets of Direct Medical Data, LLC (“DMD”) and BLM Incorporated announced on September 18, 2009, DMD’s three partners, Norman E. Swanson, Louis D. Dixon and Robert J. Sbarbaro, have been named directors of DMD Marketing Corp., a wholly-owned subsidiary of an affiliate of Aptilon. In addition, Mr. Sbarbaro has been appointed Senior Vice-President, Sales of DMD Marketing Corp.
About Aptilon Corporation
Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach and interact with physicians via the Internet through its innovative AxcelRxSM Live video detailing (with company reps), virtual programs, peer selling and other sales and marketing programs. Leading health care companies have adopted Aptilon’s ReachNetSM Physician Access Channel, driving tens of thousands of high-quality rep-physician interactions averaging eight to ten minutes in length. Aptilon provides the infrastructure necessary for sales representatives to build physician awareness, undrstanding and preference during all stages of a product's life cycle, from pre-launch education through end stage support.
AxcelRxSM and ReachNetSM are service marks of Aptilon Corporation.
Forward-Looking Statements
This news release may contain forward-looking information. These statements relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any obligation to update or revise them to reflect new events or circumstances.
For further information please contact:
|
Mr. Denis Martineau
President
Aptilon Corporation
1-888-544-8866
|
Ross Marshall
Investor Relations
The Equicom Group
416-815-0700 x 238
|
The TSX Venture Exchange Inc. has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
|
|
